Product image of Eribulin Advanz Pharma (Eribulin Mesylate) supplied by GNH India

Eribulin Advanz Pharma

Active Ingredient:
Eribulin Mesylate
Origin:
EU

Eribulin Advanz Pharma (Eribulin Mesylate)

Eribulin Mesylate is an intravenous medication used in cancer treatment. This chemotherapy agent is designed to target and disrupt cancer cell division, offering a therapeutic option for specific types of cancer.

Manufacturer / TM Owner

Advanz Pharma Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Eribulin Mesylate is primarily used in the treatment of metastatic breast cancer and liposarcoma. It works by interfering with the cell division process, specifically targeting microtubules within cancer cells. This medication is often considered when other treatments have proven ineffective or stopped working. Patients and healthcare providers may explore its use for advanced or recurrent cancers, though individual responses can vary.

Side Effects

  • Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some patients might experience peripheral neuropathy, which can cause numbness or tingling in the hands and feet. Other potential effects include fever, constipation, and an increased risk of infections. These effects can vary in severity and duration among individuals.

Precautions & Warnings

  • Eribulin Mesylate should be administered under the supervision of a healthcare professional. It is crucial to follow all safety guidelines and precautions provided by the prescribing doctor. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment. Regular monitoring and follow-up appointments are essential to manage potential side effects and ensure the medication's effectiveness.

Avoid Interactions

  • Eribulin Mesylate may interact with other medications, including those that affect liver enzymes. It is important to discuss all current medications, including over-the-counter drugs and supplements, with a healthcare provider. Alcohol consumption should be avoided as it may exacerbate certain side effects. Patients should also be cautious with medications that suppress the immune system or affect blood cell production.

Frequently Asked Questions

Eribulin Mesylate is used to treat metastatic breast cancer and liposarcoma. It is a chemotherapy agent that targets cancer cells by disrupting their division process.

Eribulin Mesylate is administered intravenously by a healthcare professional. The dosage and frequency are determined by the prescribing doctor based on individual patient needs.

Common side effects may include fatigue, nausea, hair loss, and peripheral neuropathy. Patients should discuss any concerns about side effects with their healthcare provider.

Eribulin Mesylate may interact with other medications, so it is important to inform your healthcare provider about all current medications before starting treatment.

Patients should follow all safety guidelines provided by their healthcare provider, inform them of any existing medical conditions, and attend regular follow-up appointments.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eribulin Mesylate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT